US20030068362A1
(en)
*
|
1993-02-22 |
2003-04-10 |
American Bioscience, Inc. |
Methods and formulations for the delivery of pharmacologically active agents
|
US6753006B1
(en)
|
1993-02-22 |
2004-06-22 |
American Bioscience, Inc. |
Paclitaxel-containing formulations
|
US6096331A
(en)
|
1993-02-22 |
2000-08-01 |
Vivorx Pharmaceuticals, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US6749868B1
(en)
*
|
1993-02-22 |
2004-06-15 |
American Bioscience, Inc. |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6537579B1
(en)
*
|
1993-02-22 |
2003-03-25 |
American Bioscience, Inc. |
Compositions and methods for administration of pharmacologically active compounds
|
US20030133955A1
(en)
*
|
1993-02-22 |
2003-07-17 |
American Bioscience, Inc. |
Methods and compositions useful for administration of chemotherapeutic agents
|
US5439686A
(en)
*
|
1993-02-22 |
1995-08-08 |
Vivorx Pharmaceuticals, Inc. |
Methods for in vivo delivery of substantially water insoluble pharmacologically active agents and compositions useful therefor
|
US20070122465A1
(en)
*
|
1993-02-22 |
2007-05-31 |
Desai Neil P |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
EP0693924B2
(de)
*
|
1993-02-22 |
2008-04-09 |
Abraxis BioScience, Inc. |
Verfahren für die in-vivo-verabreichung von biologischen substanzen und hierfür verwendbare zusammensetzungen
|
US6774278B1
(en)
|
1995-06-07 |
2004-08-10 |
Cook Incorporated |
Coated implantable medical device
|
US6143211A
(en)
*
|
1995-07-21 |
2000-11-07 |
Brown University Foundation |
Process for preparing microparticles through phase inversion phenomena
|
US20070092563A1
(en)
*
|
1996-10-01 |
2007-04-26 |
Abraxis Bioscience, Inc. |
Novel formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
US20030203036A1
(en)
|
2000-03-17 |
2003-10-30 |
Gordon Marc S. |
Systems and processes for spray drying hydrophobic drugs with hydrophilic excipients
|
GB9703673D0
(en)
*
|
1997-02-21 |
1997-04-09 |
Bradford Particle Design Ltd |
Method and apparatus for the formation of particles
|
US8853260B2
(en)
*
|
1997-06-27 |
2014-10-07 |
Abraxis Bioscience, Llc |
Formulations of pharmacological agents, methods for the preparation thereof and methods for the use thereof
|
KR101180181B1
(ko)
*
|
1997-06-27 |
2012-09-05 |
아브락시스 바이오사이언스, 엘엘씨 |
나노 입자 및 그의 제조 방법
|
US20030199425A1
(en)
*
|
1997-06-27 |
2003-10-23 |
Desai Neil P. |
Compositions and methods for treatment of hyperplasia
|
CN100462066C
(zh)
*
|
1997-06-27 |
2009-02-18 |
美国生物科学有限公司 |
药剂的新制剂及其制备和应用方法
|
WO1999012571A1
(fr)
*
|
1997-09-05 |
1999-03-18 |
Maruho Kabushikikaisha |
Preparations de nanocapsules destinees au traitement de maladies intra-articulaires
|
HUP9701554D0
(en)
*
|
1997-09-18 |
1997-11-28 |
Human Oltoanyagtermeloe Gyogys |
Pharmaceutical composition containing plazma proteins
|
US6884842B2
(en)
|
1997-10-14 |
2005-04-26 |
Alnis Biosciences, Inc. |
Molecular compounds having complementary surfaces to targets
|
US20030059465A1
(en)
*
|
1998-05-11 |
2003-03-27 |
Unger Evan C. |
Stabilized nanoparticle formulations of camptotheca derivatives
|
WO2000006152A1
(en)
*
|
1998-07-30 |
2000-02-10 |
Novopharm Biotech, Inc. |
Pharmaceutically acceptable composition comprising an aqueous solution of paclitaxel and albumin
|
GB9820746D0
(en)
†
|
1998-09-23 |
1998-11-18 |
Pharmax Limited |
Micronised pharmaceutical compositions
|
US8293277B2
(en)
*
|
1998-10-01 |
2012-10-23 |
Alkermes Pharma Ireland Limited |
Controlled-release nanoparticulate compositions
|
WO2000018374A1
(en)
*
|
1998-10-01 |
2000-04-06 |
Elan Pharma International, Ltd. |
Controlled release nanoparticulate compositions
|
US20040013613A1
(en)
*
|
2001-05-18 |
2004-01-22 |
Jain Rajeev A |
Rapidly disintegrating solid oral dosage form
|
US8236352B2
(en)
*
|
1998-10-01 |
2012-08-07 |
Alkermes Pharma Ireland Limited |
Glipizide compositions
|
AT406054B
(de)
*
|
1998-11-04 |
2000-02-25 |
Andreas Bernkop-Schnuerch |
Verfahren zur verbesserung der mucoadhäsion von polymeren sowie deren herstellung und verwendung
|
US20040141925A1
(en)
*
|
1998-11-12 |
2004-07-22 |
Elan Pharma International Ltd. |
Novel triamcinolone compositions
|
US6428814B1
(en)
*
|
1999-10-08 |
2002-08-06 |
Elan Pharma International Ltd. |
Bioadhesive nanoparticulate compositions having cationic surface stabilizers
|
US7521068B2
(en)
*
|
1998-11-12 |
2009-04-21 |
Elan Pharma International Ltd. |
Dry powder aerosols of nanoparticulate drugs
|
DE19856432A1
(de)
*
|
1998-12-08 |
2000-06-15 |
Basf Ag |
Nanopartikuläre Kern-Schale Systeme sowie deren Verwendung in pharmazeutischen und kosmetischen Zubereitungen
|
WO2002085337A1
(en)
*
|
2001-04-20 |
2002-10-31 |
The University Of British Columbia |
Micellar drug delivery systems for hydrophobic drugs
|
DE19919769A1
(de)
|
1999-04-30 |
2000-11-02 |
Henkel Kgaa |
Verwendung nanoskaliger antimikrobieller Wirkstoffe in Körperdeodorantien
|
GB9910975D0
(en)
*
|
1999-05-13 |
1999-07-14 |
Univ Strathclyde |
Rapid dehydration of proteins
|
AU784416B2
(en)
*
|
1999-05-21 |
2006-03-30 |
Abraxis Bioscience, Llc |
Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof
|
US6610317B2
(en)
|
1999-05-27 |
2003-08-26 |
Acusphere, Inc. |
Porous paclitaxel matrices and methods of manufacture thereof
|
GB2350297A
(en)
*
|
1999-05-27 |
2000-11-29 |
Abbott Lab |
Injectable halogenated anesthetic formulation in emulsion form
|
US7919119B2
(en)
*
|
1999-05-27 |
2011-04-05 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
US20090104273A1
(en)
*
|
1999-06-22 |
2009-04-23 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
US20040115134A1
(en)
*
|
1999-06-22 |
2004-06-17 |
Elan Pharma International Ltd. |
Novel nifedipine compositions
|
DE19932157A1
(de)
*
|
1999-07-13 |
2001-01-18 |
Pharmasol Gmbh |
Verfahren zur schonenden Herstellung von hochfeinen Mikropartikeln und Nanopartikeln
|
US6656504B1
(en)
|
1999-09-09 |
2003-12-02 |
Elan Pharma International Ltd. |
Nanoparticulate compositions comprising amorphous cyclosporine and methods of making and using such compositions
|
PT1221968E
(pt)
*
|
1999-10-13 |
2010-04-16 |
Novartis Vaccines & Diagnostic |
Processo de obtenção de respostas imunes celulares de proteínas
|
US20020041898A1
(en)
*
|
2000-01-05 |
2002-04-11 |
Unger Evan C. |
Novel targeted delivery systems for bioactive agents
|
EP1246608A4
(de)
*
|
2000-01-05 |
2005-05-18 |
Imarx Therapeutics Inc |
PHARMAZEUTISCHE ZUBEREITUNGEN ZUR VERABREICHUNG VON WIRKSTOFFEN MIT GERINGER WASSERLöSLICHKEIT
|
US20040009229A1
(en)
*
|
2000-01-05 |
2004-01-15 |
Unger Evan Charles |
Stabilized nanoparticle formulations of camptotheca derivatives
|
GB2359747B
(en)
*
|
2000-02-29 |
2002-04-24 |
Maelor Pharmaceuticals Ltd |
Anaesthetic formulations
|
WO2001070197A2
(en)
*
|
2000-03-23 |
2001-09-27 |
Collaborative Technologies, Inc. |
Method for preparing high pressure/high shear dispersions containing physiologically active ingredients
|
ITMI20001107A1
(it)
*
|
2000-05-18 |
2001-11-18 |
Acs Dobfar Spa |
Metodo per il trattamento di tumori solici mediante microparticelle di albumina incorporanti paclitaxel
|
US20040156872A1
(en)
*
|
2000-05-18 |
2004-08-12 |
Elan Pharma International Ltd. |
Novel nimesulide compositions
|
DE10036871A1
(de)
*
|
2000-07-28 |
2002-02-14 |
Pharmasol Gmbh |
Dispersionen zur Formulierung wenig oder schwer löslicher Wirkstoffe
|
US6623765B1
(en)
*
|
2000-08-01 |
2003-09-23 |
University Of Florida, Research Foundation, Incorporated |
Microemulsion and micelle systems for solubilizing drugs
|
US7198795B2
(en)
|
2000-09-21 |
2007-04-03 |
Elan Pharma International Ltd. |
In vitro methods for evaluating the in vivo effectiveness of dosage forms of microparticulate of nanoparticulate active agent compositions
|
CA2423484A1
(en)
|
2000-09-27 |
2002-04-04 |
Verion Inc. |
Instant water dissolvable encapsulate and process
|
EP1324885A1
(de)
*
|
2000-10-02 |
2003-07-09 |
Kimberly-Clark Worldwide, Inc. |
Nanopartikel enthaltendes aufzeichnungsmedium und verfahren zu dessen herstellung
|
GB0027357D0
(en)
|
2000-11-09 |
2000-12-27 |
Bradford Particle Design Plc |
Particle formation methods and their products
|
ATE413164T1
(de)
|
2000-11-09 |
2008-11-15 |
Neopharm Inc |
Sn-38-lipidkomplexe und verfahren zu ihrer verwendung
|
US6977085B2
(en)
*
|
2000-12-22 |
2005-12-20 |
Baxter International Inc. |
Method for preparing submicron suspensions with polymorph control
|
US20040256749A1
(en)
*
|
2000-12-22 |
2004-12-23 |
Mahesh Chaubal |
Process for production of essentially solvent-free small particles
|
US9700866B2
(en)
*
|
2000-12-22 |
2017-07-11 |
Baxter International Inc. |
Surfactant systems for delivery of organic compounds
|
US6884436B2
(en)
*
|
2000-12-22 |
2005-04-26 |
Baxter International Inc. |
Method for preparing submicron particle suspensions
|
US20050048126A1
(en)
*
|
2000-12-22 |
2005-03-03 |
Barrett Rabinow |
Formulation to render an antimicrobial drug potent against organisms normally considered to be resistant to the drug
|
US8067032B2
(en)
|
2000-12-22 |
2011-11-29 |
Baxter International Inc. |
Method for preparing submicron particles of antineoplastic agents
|
US7193084B2
(en)
*
|
2000-12-22 |
2007-03-20 |
Baxter International Inc. |
Polymorphic form of itraconazole
|
US7037528B2
(en)
*
|
2000-12-22 |
2006-05-02 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US6951656B2
(en)
*
|
2000-12-22 |
2005-10-04 |
Baxter International Inc. |
Microprecipitation method for preparing submicron suspensions
|
US20030096013A1
(en)
*
|
2000-12-22 |
2003-05-22 |
Jane Werling |
Preparation of submicron sized particles with polymorph control
|
US7115565B2
(en)
|
2001-01-18 |
2006-10-03 |
Pharmacia & Upjohn Company |
Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
|
US20040022861A1
(en)
*
|
2001-01-30 |
2004-02-05 |
Williams Robert O. |
Process for production of nanoparticles and microparticles by spray freezing into liquid
|
US20030157170A1
(en)
*
|
2001-03-13 |
2003-08-21 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
CA2440935A1
(en)
*
|
2001-03-13 |
2002-09-19 |
Richard Liggins |
Micellar drug delivery vehicles and precursors thereto and uses thereof
|
DE10115740A1
(de)
*
|
2001-03-26 |
2002-10-02 |
Ulrich Speck |
Zubereitung für die Restenoseprophylaxe
|
CA2441108A1
(en)
*
|
2001-04-05 |
2002-10-17 |
Universite Laval |
Process for making delivery matrix and uses thereof
|
SG126676A1
(en)
*
|
2001-05-09 |
2007-01-30 |
Nanomaterials Tech Pte Ltd |
Process for the controlled production of organic particles
|
WO2003030864A1
(en)
*
|
2001-05-29 |
2003-04-17 |
Neopharm, Inc. |
Liposomal formulation of irinotecan
|
CA2451187C
(en)
*
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
GB0116074D0
(en)
*
|
2001-06-29 |
2001-08-22 |
Univ Strathclyde |
Nanoparticle structures
|
US20040013698A1
(en)
*
|
2001-07-09 |
2004-01-22 |
Aust Duncan T |
Method for preparing topical preparations containing skin protective agents with enhanced barrier properties
|
TWI297335B
(en)
|
2001-07-10 |
2008-06-01 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
TWI252847B
(en)
*
|
2001-07-10 |
2006-04-11 |
Synta Pharmaceuticals Corp |
Synthesis of taxol enhancers
|
TWI332943B
(en)
*
|
2001-07-10 |
2010-11-11 |
Synta Pharmaceuticals Corp |
Taxol enhancer compounds
|
US20040018250A1
(en)
*
|
2001-07-11 |
2004-01-29 |
Ceccoli Joseph D. |
Methods for preparing high pressure/high shear dispersions containing waxes and other semi-solids and oils
|
CA2456806C
(en)
*
|
2001-08-08 |
2011-10-18 |
Brown University Research Foundation |
Methods for micronization of hydrophobic drugs
|
US20030199587A1
(en)
*
|
2001-08-14 |
2003-10-23 |
Franz G. Andrew |
Levothyroxine compositions having unique Cmax properties
|
US20030054042A1
(en)
*
|
2001-09-14 |
2003-03-20 |
Elaine Liversidge |
Stabilization of chemical compounds using nanoparticulate formulations
|
JP2005504090A
(ja)
*
|
2001-09-26 |
2005-02-10 |
バクスター・インターナショナル・インコーポレイテッド |
分散体および溶媒相または液相の除去によるサブミクロンサイズ−ナノ粒子の調製
|
US20060003012A9
(en)
|
2001-09-26 |
2006-01-05 |
Sean Brynjelsen |
Preparation of submicron solid particle suspensions by sonication of multiphase systems
|
WO2003032906A2
(en)
*
|
2001-10-15 |
2003-04-24 |
Crititech, Inc. |
Delivery of poorly soluble drugs
|
JPWO2003034302A1
(ja)
*
|
2001-10-15 |
2005-02-03 |
株式会社シュタルク |
コンテンツ配信用サーバ及びこれを備えたコンテンツ配信システム
|
KR100982466B1
(ko)
|
2001-10-19 |
2010-09-16 |
이소테크니카 인코포레이티드 |
시클로스포린 유사체의 합성
|
US7112340B2
(en)
*
|
2001-10-19 |
2006-09-26 |
Baxter International Inc. |
Compositions of and method for preparing stable particles in a frozen aqueous matrix
|
WO2003037359A1
(fr)
*
|
2001-10-29 |
2003-05-08 |
Chengdu Somo Namotechnology Co., Ltd. |
Nanoparticule de composants de medicaments insolubles et procede de production correspondant
|
US20040101566A1
(en)
*
|
2002-02-04 |
2004-05-27 |
Elan Pharma International Limited |
Novel benzoyl peroxide compositions
|
AU2003210517A1
(en)
*
|
2002-02-04 |
2003-09-02 |
Elan Pharma International, Ltd. |
Drug nanoparticles with lysozyme surface stabiliser
|
US20080220075A1
(en)
*
|
2002-03-20 |
2008-09-11 |
Elan Pharma International Ltd. |
Nanoparticulate compositions of angiogenesis inhibitors
|
DE60309300T3
(de)
*
|
2002-03-20 |
2011-02-24 |
Elan Pharma International Ltd. |
Nanopartikelzusammensetzungen von angiogeneseinhibitoren
|
US20040076586A1
(en)
*
|
2002-03-28 |
2004-04-22 |
Reinhard Koening |
Compositions and methods for delivering pharmaceutically active agents using nanoparticulates
|
US20040082521A1
(en)
*
|
2002-03-29 |
2004-04-29 |
Azaya Therapeutics Inc. |
Novel formulations of digitalis glycosides for treating cell-proliferative and other diseases
|
ITMI20020680A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Composizione antitumorale migliorata a base di paclitaxel e metodo per il suo ottenimento
|
ITMI20020681A1
(it)
*
|
2002-03-29 |
2003-09-29 |
Acs Dobfar Spa |
Procedimento per la produzione di nanoparticelle di paclitaxel ed albumina
|
WO2003090717A1
(en)
*
|
2002-04-23 |
2003-11-06 |
Nanotherapeutics, Inc |
Process of forming and modifying particles and compositions produced thereby
|
GB0216562D0
(en)
|
2002-04-25 |
2002-08-28 |
Bradford Particle Design Ltd |
Particulate materials
|
US9339459B2
(en)
|
2003-04-24 |
2016-05-17 |
Nektar Therapeutics |
Particulate materials
|
DE60335801D1
(de)
*
|
2002-07-12 |
2011-03-03 |
Cook William Europ |
Beschichtete medizinische vorrichtung
|
AU2003247671B2
(en)
*
|
2002-07-15 |
2008-02-14 |
Alcon, Inc. |
Bioerodible film for ophthalmic drug delivery
|
US20040258757A1
(en)
*
|
2002-07-16 |
2004-12-23 |
Elan Pharma International, Ltd. |
Liquid dosage compositions of stable nanoparticulate active agents
|
GB0216700D0
(en)
*
|
2002-07-18 |
2002-08-28 |
Astrazeneca Ab |
Process
|
DE10234165B4
(de)
*
|
2002-07-26 |
2008-01-03 |
Advanced Micro Devices, Inc., Sunnyvale |
Verfahren zum Füllen eines Grabens, der in einem Substrat gebildet ist, mit einem isolierenden Material
|
RU2005103625A
(ru)
*
|
2002-08-12 |
2005-08-20 |
Пфайзер Продактс Инк. (Us) |
Фармацевтические композиции полуупорядоченных лекарств и полимеров
|
US20060030578A1
(en)
*
|
2002-08-20 |
2006-02-09 |
Neopharm, Inc. |
Pharmaceutically active lipid based formulation of irinotecan
|
AU2003296897A1
(en)
*
|
2002-08-20 |
2004-05-04 |
Neopharm, Inc. |
Pharmaceutical formulations of camptothecine derivatives
|
US7090868B2
(en)
*
|
2002-09-13 |
2006-08-15 |
University Of Florida |
Materials and methods for drug delivery and uptake
|
US20050051922A1
(en)
*
|
2002-09-20 |
2005-03-10 |
Avinash Nangia |
Pharmaceutical composition with sodium lauryl sulfate as an extra-granular absorption/compression enhancer and the process to make the same
|
DE10244847A1
(de)
*
|
2002-09-20 |
2004-04-01 |
Ulrich Prof. Dr. Speck |
Medizinische Vorrichtung zur Arzneimittelabgabe
|
WO2004032947A1
(en)
*
|
2002-10-09 |
2004-04-22 |
Unibioscreen S.A. |
Extract with anti-tumor and anti-poisonous activity
|
WO2004039355A1
(en)
*
|
2002-10-28 |
2004-05-13 |
Polymerix Corporation |
Therapeutic compositions
|
WO2004098570A1
(en)
*
|
2002-10-30 |
2004-11-18 |
Spherics, Inc. |
Nanoparticulate bioactive agents
|
EP1585504A4
(de)
*
|
2002-11-06 |
2009-07-15 |
Azaya Therapeutics Inc |
Proteinstabilisierte liposomale formulierungen pharmazeutischer wirkstoffe
|
WO2004045494A2
(en)
*
|
2002-11-20 |
2004-06-03 |
Bar-Ilan University |
Biological glue based on thrombin-conjugated nanoparticles
|
RU2361615C2
(ru)
*
|
2002-12-09 |
2009-07-20 |
Абраксис Байосайенс, Ллс. |
Композиции и способы доставки фармакологических агентов
|
TR200502189T1
(tr)
*
|
2002-12-09 |
2007-01-22 |
American Bioscience, Inc. |
Kompozisyonlar ve farmakolojik etken maddelerin aktarımı için yöntemler.
|
KR20110079741A
(ko)
*
|
2002-12-09 |
2011-07-07 |
아브락시스 바이오사이언스, 엘엘씨 |
약리학적 물질의 조성물 및 그 전달방법
|
US8409618B2
(en)
|
2002-12-20 |
2013-04-02 |
Kimberly-Clark Worldwide, Inc. |
Odor-reducing quinone compounds
|
US6780896B2
(en)
*
|
2002-12-20 |
2004-08-24 |
Kimberly-Clark Worldwide, Inc. |
Stabilized photoinitiators and applications thereof
|
US7666410B2
(en)
|
2002-12-20 |
2010-02-23 |
Kimberly-Clark Worldwide, Inc. |
Delivery system for functional compounds
|
TWI330079B
(en)
*
|
2003-01-15 |
2010-09-11 |
Synta Pharmaceuticals Corp |
Treatment for cancers
|
EP1442753B1
(de)
*
|
2003-02-03 |
2007-02-21 |
Polaschegg, Hans-Dietrich, Dr.techn. |
Zusammensetzung zur Prävention von Infektionen durch subkutane Prothesen
|
GB0302673D0
(en)
|
2003-02-06 |
2003-03-12 |
Astrazeneca Ab |
Pharmaceutical formulations
|
US7968115B2
(en)
|
2004-03-05 |
2011-06-28 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of cancer
|
WO2004080396A2
(en)
*
|
2003-03-07 |
2004-09-23 |
The University Of Texas Md Anderson Cancer Center |
Liposomal curcumin for treatment of cancer
|
US20040225022A1
(en)
*
|
2003-05-09 |
2004-11-11 |
Desai Neil P. |
Propofol formulation containing reduced oil and surfactants
|
US20040247624A1
(en)
*
|
2003-06-05 |
2004-12-09 |
Unger Evan Charles |
Methods of making pharmaceutical formulations for the delivery of drugs having low aqueous solubility
|
US8476010B2
(en)
*
|
2003-07-10 |
2013-07-02 |
App Pharmaceuticals Llc |
Propofol formulations with non-reactive container closures
|
US20050181018A1
(en)
*
|
2003-09-19 |
2005-08-18 |
Peyman Gholam A. |
Ocular drug delivery
|
BRPI0414858A
(pt)
*
|
2003-10-02 |
2006-11-21 |
Sembiosys Genetics Inc |
métodos para preparação de corpos de óleo compreendendo ingredientes ativos
|
US7488520B2
(en)
|
2003-10-16 |
2009-02-10 |
Kimberly-Clark Worldwide, Inc. |
High surface area material blends for odor reduction, articles utilizing such blends and methods of using same
|
US7438875B2
(en)
*
|
2003-10-16 |
2008-10-21 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using metal-modified silica particles
|
US7413550B2
(en)
|
2003-10-16 |
2008-08-19 |
Kimberly-Clark Worldwide, Inc. |
Visual indicating device for bad breath
|
US7879350B2
(en)
*
|
2003-10-16 |
2011-02-01 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using colloidal nanoparticles
|
US7837663B2
(en)
*
|
2003-10-16 |
2010-11-23 |
Kimberly-Clark Worldwide, Inc. |
Odor controlling article including a visual indicating device for monitoring odor absorption
|
US7794737B2
(en)
|
2003-10-16 |
2010-09-14 |
Kimberly-Clark Worldwide, Inc. |
Odor absorbing extrudates
|
US7754197B2
(en)
|
2003-10-16 |
2010-07-13 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using coordinated polydentate compounds
|
US7678367B2
(en)
|
2003-10-16 |
2010-03-16 |
Kimberly-Clark Worldwide, Inc. |
Method for reducing odor using metal-modified particles
|
WO2005062985A2
(en)
*
|
2003-12-23 |
2005-07-14 |
American Bioscience, Inc. |
Di-ester prodrugs of camptothecin, process for their preparation and their therapeutical applications
|
WO2005063665A1
(en)
|
2003-12-23 |
2005-07-14 |
Abraxis Bioscience, Inc |
Propofol analogs, process for their preparation, and methods of use
|
CA2551117A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Abraxis Bioscience, Inc. |
Substituted melatonin derivatives, process for their preparation, and methods of use
|
US20050186230A1
(en)
*
|
2004-01-23 |
2005-08-25 |
Sd Pharmaceuticals, Inc. |
Elemene compositions containing liquid oil
|
EP1713514B1
(de)
*
|
2004-01-28 |
2021-11-24 |
Johns Hopkins University |
Arzneimittel und genträgerteilchen, die sich schnell durch schleimhautbarrieren bewegen
|
EP1711163A2
(de)
*
|
2004-02-05 |
2006-10-18 |
Baxter International Inc. |
Unter verwendung von selbststabilisierenden mitteln hergestellte dispersionen
|
US20080103213A1
(en)
*
|
2004-03-05 |
2008-05-01 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of neurofibromatosis
|
US8784881B2
(en)
*
|
2004-03-05 |
2014-07-22 |
Board Of Regents, The University Of Texas System |
Liposomal curcumin for treatment of diseases
|
JP2007532645A
(ja)
*
|
2004-04-13 |
2007-11-15 |
アルザ コーポレイション |
フェンタニルに基づく薬剤の経皮送達システム用の器具および方法
|
CA2469339A1
(en)
*
|
2004-06-07 |
2005-12-07 |
Bernard Charles Sherman |
Sustained release propafenone hydrochloride capsules
|
WO2006009940A1
(en)
*
|
2004-06-23 |
2006-01-26 |
Synta Pharmaceuticals Corp. |
Bis(thio-hydrazide amide) salts for treatment of cancers
|
JP4433918B2
(ja)
*
|
2004-07-15 |
2010-03-17 |
コニカミノルタエムジー株式会社 |
画像形成方法
|
KR100578382B1
(ko)
|
2004-07-16 |
2006-05-11 |
나재운 |
항암제의 전달체용 수용성 키토산 나노입자 및 그 제조방법
|
KR100651728B1
(ko)
*
|
2004-11-10 |
2006-12-06 |
한국전자통신연구원 |
정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
|
US20060198891A1
(en)
*
|
2004-11-29 |
2006-09-07 |
Francois Ravenelle |
Solid formulations of liquid biologically active agents
|
MX2007007342A
(es)
*
|
2004-12-15 |
2007-12-11 |
Elan Pharma Int Ltd |
Formulaciones de tacrolimus nanoparticuladas.
|
HUE038768T2
(hu)
*
|
2005-02-18 |
2018-11-28 |
Abraxis Bioscience Llc |
Terápiás szerek kombinációi, valamint beadásukra szolgáló módszerek, és kombinációs terápia
|
US20070166388A1
(en)
|
2005-02-18 |
2007-07-19 |
Desai Neil P |
Combinations and modes of administration of therapeutic agents and combination therapy
|
JP2008530236A
(ja)
|
2005-02-18 |
2008-08-07 |
アブラクシス バイオサイエンス、インコーポレイテッド |
虚血障害用の、2,6−ジイソプロピルフェノール及び類似体の組成物、使用及び調製方法。
|
US8735394B2
(en)
|
2005-02-18 |
2014-05-27 |
Abraxis Bioscience, Llc |
Combinations and modes of administration of therapeutic agents and combination therapy
|
US8415388B2
(en)
|
2005-02-22 |
2013-04-09 |
Savvipharm Inc. |
Pharmaceutical compositions containing paclitaxel orotate
|
EA200701998A1
(ru)
*
|
2005-03-17 |
2008-02-28 |
Элан Фарма Интернэшнл Лтд. |
Композиции для инъекций наночастиц иммунодепрессивных соединений
|
US20060229585A1
(en)
*
|
2005-04-11 |
2006-10-12 |
Minu, L.L.C. |
Drug delivery to the crystalline lens and other ocular structures
|
US7722581B2
(en)
*
|
2005-04-11 |
2010-05-25 |
Gholam A. Peyman |
Crystalline lens drug delivery
|
JP2008535924A
(ja)
|
2005-04-12 |
2008-09-04 |
エラン ファーマ インターナショナル リミテッド |
ナノ粒子キナゾリン誘導体製剤
|
US8017654B2
(en)
*
|
2005-04-15 |
2011-09-13 |
Synta Pharmaceuticals Corp. |
Combination cancer therapy with bis(thiohydrazide) amide compounds
|
MX2007015183A
(es)
*
|
2005-06-14 |
2008-02-19 |
Baxter Int |
Formulaciones farmaceuticas para minimizar las interacciones farmaco-farmaco.
|
US20060280787A1
(en)
*
|
2005-06-14 |
2006-12-14 |
Baxter International Inc. |
Pharmaceutical formulation of the tubulin inhibitor indibulin for oral administration with improved pharmacokinetic properties, and process for the manufacture thereof
|
TWI417114B
(zh)
|
2005-08-31 |
2013-12-01 |
Abraxis Bioscience Llc |
具有增強穩定性之弱水溶性藥物之組合物及其製備方法
|
CN101291658B
(zh)
|
2005-08-31 |
2014-04-16 |
阿布拉科斯生物科学有限公司 |
用于制备稳定性增加的水难溶性药物的组合物和方法
|
CN101273066B
(zh)
*
|
2005-09-09 |
2013-10-16 |
郑特来 |
用于递送抗癌剂的水溶性壳聚糖纳米颗粒及其制备方法
|
US20070098802A1
(en)
*
|
2005-10-31 |
2007-05-03 |
Isaac Farr |
Organic nanoparticles and associated methods
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
ES2564241T3
(es)
*
|
2005-12-02 |
2016-03-21 |
Glaxosmithkline Biologicals Sa |
Nanopartículas para su uso en composiciones inmunogénicas
|
DE102005062440B4
(de)
*
|
2005-12-27 |
2011-02-24 |
Lts Lohmann Therapie-Systeme Ag |
Proteinbasiertes Trägersystem zur Resistenzüberwindung von Tumorzellen
|
EP1971622B1
(de)
|
2005-12-28 |
2011-10-19 |
Fresenius Kabi Oncology Limited |
Biokompatibles, nicht biologisch abbaubares, nichttoxisches polymer, das zur verwendung für pharmazeutische nanopartikelzusammensetzungen geeignet ist
|
SE0600091L
(sv)
|
2006-01-18 |
2007-04-17 |
Bows Pharmaceuticals Ag |
Förfarande för framställning av en dextranmatris för kontrollerad frisättning av insulin
|
AR054215A1
(es)
|
2006-01-20 |
2007-06-13 |
Eriochem Sa |
Una formulacion farmaceutica de un taxano, una composicion solida de un taxano liofilizado a partir de una solucion de acido acetico, un procedimiento para la preparacion de dicha composicion solida de un taxano, una composicion solubilizante de un taxano liofilizado, y un conjunto de elementos (kit
|
JP4974533B2
(ja)
*
|
2006-01-30 |
2012-07-11 |
富士フイルム株式会社 |
ジスルフィド架橋したタンパク質ナノ粒子
|
US8367112B2
(en)
*
|
2006-02-28 |
2013-02-05 |
Alkermes Pharma Ireland Limited |
Nanoparticulate carverdilol formulations
|
US7458953B2
(en)
*
|
2006-06-20 |
2008-12-02 |
Gholam A. Peyman |
Ocular drainage device
|
JP5571380B2
(ja)
*
|
2006-07-24 |
2014-08-13 |
ルミナス バイオサイエンシズ,インコーポレイテッド |
オストワルド熟成を減少させた水不溶性の医薬品物質の固体ナノ粒子処方物
|
TWI440632B
(zh)
|
2006-08-21 |
2014-06-11 |
Synta Pharmaceuticals Corp |
用於治療增生性疾病的化合物
|
AU2007290490B2
(en)
*
|
2006-08-31 |
2011-09-08 |
Synta Pharmaceuticals Corp. |
Combination with bis(thiohydrazide amides) for treating cancer
|
US20080280987A1
(en)
*
|
2006-08-31 |
2008-11-13 |
Desai Neil P |
Methods of inhibiting angiogenesis and treating angiogenesis-associated diseases
|
EP2061433B1
(de)
*
|
2006-09-08 |
2011-02-16 |
Johns Hopkins University |
Zusammensetzungen zur transportintensivierung durch die schleimhaut
|
US9498528B2
(en)
*
|
2006-09-13 |
2016-11-22 |
Genzyme Corporation |
Treatment of multiple sclerosis (MS)
|
AR063704A1
(es)
|
2006-09-14 |
2009-02-11 |
Makhteshim Chem Works Ltd |
Nanoparticulas de pesticida obtenida obtenidas a partir de microemulsiones y nanoemulsiones
|
WO2008032327A2
(en)
*
|
2006-09-14 |
2008-03-20 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Organic nanoparticles obtained from microemulsions by solvent evaporation
|
WO2008036858A2
(en)
|
2006-09-20 |
2008-03-27 |
The Board Of Regents Of The University Of Texas System |
Methods for delivering volatile anesthetics for regional anesthesia and/or pain relief
|
JP5099545B2
(ja)
*
|
2006-10-17 |
2012-12-19 |
公立大学法人大阪府立大学 |
化合物の溶解補助剤とそれを含む組成物
|
ATE520666T1
(de)
*
|
2006-11-15 |
2011-09-15 |
Abraxis Bioscience Llc |
Derivate von 18-amino-substituierten analoga des geldamycin-hydrochinons mit cyctotoxischer wirkung für die behandlung von krebs
|
US7799954B2
(en)
*
|
2006-11-17 |
2010-09-21 |
Abraxis Bioscience, Llc |
Dicarbonyl derivatives and methods of use
|
SI2117520T1
(sl)
|
2006-12-14 |
2019-01-31 |
Abraxis Bioscience, Llc |
Zdravljenje raka dojk glede na status hormonskih receptorjev z nano delci, ki zajemajo taksan
|
WO2008076883A2
(en)
*
|
2006-12-15 |
2008-06-26 |
Abraxis Bioscience, Inc. |
Triazine derivatives and their therapeutical applications
|
MX2009009537A
(es)
|
2007-03-07 |
2009-09-16 |
Abraxis Bioscience Llc |
Nanoparticula que comprende rapamicina y albumina como agente anticancer.
|
WO2008137148A2
(en)
|
2007-05-03 |
2008-11-13 |
Abraxis Bioscience, Llc |
Methods and compositions for treating pulmonary hypertension
|
US8722736B2
(en)
|
2007-05-22 |
2014-05-13 |
Baxter International Inc. |
Multi-dose concentrate esmolol with benzyl alcohol
|
US8426467B2
(en)
|
2007-05-22 |
2013-04-23 |
Baxter International Inc. |
Colored esmolol concentrate
|
WO2008150532A1
(en)
*
|
2007-06-01 |
2008-12-11 |
Abraxis Bioscience, Llc |
Methods and compositions for treating recurrent cancer
|
WO2009036368A2
(en)
*
|
2007-09-14 |
2009-03-19 |
Nitto Denko Corporation |
Drug carriers
|
AR063111A1
(es)
|
2007-10-03 |
2008-12-30 |
Eriochem Sa |
Una formulacion farmaceutica de taxano
|
CN107661293A
(zh)
|
2008-01-22 |
2018-02-06 |
得克萨斯大学体系董事会 |
用于局部麻醉和/或疼痛缓解的含有萃取溶剂的挥发性麻醉剂组合物
|
CA2721153C
(en)
*
|
2008-04-10 |
2018-10-02 |
Abraxis Bioscience, Llc |
Compositions of hydrophobic taxane derivatives and uses thereof
|
KR20150136137A
(ko)
*
|
2008-04-10 |
2015-12-04 |
아브락시스 바이오사이언스, 엘엘씨 |
소수성 탁산 유도체의 조성물 및 그의 용도
|
US9126025B2
(en)
*
|
2008-05-01 |
2015-09-08 |
Bayer Intellectual Property Gmbh |
Method of coating a folded catheter balloon
|
CN101658516B
(zh)
*
|
2008-08-26 |
2011-10-05 |
齐鲁制药有限公司 |
紫杉醇类药物组合物及其制备方法
|
NZ593343A
(en)
|
2008-12-11 |
2013-04-26 |
Abraxis Bioscience Llc |
Combination cancer treatment conprising Abraxane and an inflamatory inhibitor
|
MX2011009452A
(es)
|
2009-03-13 |
2011-11-29 |
Abraxis Bioscience Llc |
Terapia de combinacion con derivados tiocolchicina.
|
US7828996B1
(en)
|
2009-03-27 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Method for the manufacture of stable, nano-sized particles
|
DK2419732T3
(da)
|
2009-04-15 |
2019-12-16 |
Abraxis Bioscience Llc |
Prionfrie nanopartikelsammensætninger og fremgangsmåder
|
EP2440053A4
(de)
|
2009-06-09 |
2012-10-31 |
California Capital Equity Llc |
Benzylsubstituierte triazinderivate und ihre therapeutischen anwendungen
|
ES2557453T3
(es)
|
2009-06-09 |
2016-01-26 |
Nantbioscience, Inc. |
Derivados de isoquinolina, quinolina y quinazolina como inhibidores de la señalización de Hedgehog
|
CN102573480B
(zh)
|
2009-06-09 |
2015-06-10 |
加利福尼亚资本权益有限责任公司 |
三嗪衍生物及其治疗应用
|
CN101653611B
(zh)
*
|
2009-07-23 |
2012-05-09 |
复旦大学 |
一种白蛋白-阿霉素纳米制剂及其制备方法和应用
|
WO2011017835A1
(en)
*
|
2009-08-11 |
2011-02-17 |
Nanjing University |
Preparation method of protein or peptide nanoparticles for in vivo drug delivery by unfolding and refolding
|
MX340670B
(es)
|
2009-08-25 |
2016-07-20 |
Abraxis Bioscience Llc * |
Terapia combinada con composiciones de nanoparticulas de taxano e inhibidores de hedgehog.
|
US10350364B2
(en)
|
2009-11-11 |
2019-07-16 |
Windgap Medical, Inc. |
Portable Drug Mixing and Delivery Device and Associated Methods
|
US9211283B2
(en)
|
2009-12-11 |
2015-12-15 |
Biolitec Pharma Marketing Ltd |
Nanoparticle carrier systems based on human serum albumin for photodynamic therapy
|
EP2531173B1
(de)
*
|
2010-02-03 |
2018-09-26 |
Oncbiomune, L.L.C. |
Taxan- und taxoidproteinzusammensetzungen
|
HUE027749T2
(en)
|
2010-03-26 |
2016-10-28 |
Abraxis Bioscience Llc |
Methods of treating hepatocellular carcinoma
|
NZ602635A
(en)
|
2010-03-29 |
2014-12-24 |
Abraxis Bioscience Llc |
Methods of enhancing drug delivery and effectiveness of therapeutic agents
|
RU2016119999A
(ru)
|
2010-03-29 |
2018-11-08 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы лечения онкологических заболеваний
|
CA2795289A1
(en)
|
2010-04-08 |
2011-10-13 |
Sanford-Burnham Medical Research Institute |
Methods and compositions for enhanced delivery of compounds
|
NZ708506A
(en)
|
2010-06-02 |
2016-08-26 |
Abraxis Bioscience Llc |
Methods of treating bladder cancer
|
US9399071B2
(en)
|
2010-06-04 |
2016-07-26 |
Abraxis Bioscience, Llc |
Methods of treatment of pancreatic cancer
|
RU2577278C2
(ru)
|
2010-06-07 |
2016-03-10 |
АБРАКСИС БАЙОСАЙЕНС, ЭлЭлСи |
Способы комбинированной терапии для лечения пролиферативных заболеваний
|
CN103202813B
(zh)
*
|
2010-08-09 |
2015-09-30 |
南京大学 |
一种制备用于体内递送药理活性物质的蛋白纳米粒的方法
|
CN103202812B
(zh)
*
|
2010-08-09 |
2015-10-28 |
南京大学 |
一种制备用于体内递送药理活性物质的蛋白纳米粒的方法
|
KR101223484B1
(ko)
*
|
2010-10-05 |
2013-01-17 |
한국과학기술연구원 |
사람 혈청 알부민-siRNA 나노입자 전달체
|
US8884027B2
(en)
|
2010-10-22 |
2014-11-11 |
University Of Rochester |
Melampomagnolide B derivatives as antileukemic and cytotoxic agents
|
MX350838B
(es)
|
2011-02-11 |
2017-09-18 |
Grain Proc Corporation * |
Composicion de sal.
|
WO2012118778A1
(en)
|
2011-02-28 |
2012-09-07 |
Sanford-Burnham Medical Research Institute |
Truncated car peptides and methods and compositions using truncated car peptides
|
RU2475247C2
(ru)
*
|
2011-03-05 |
2013-02-20 |
Республика Северная Осетия-Алания "Всероссийское общество изобретателей и рационализаторов" ("ВОИР") |
Способ профилактики несостоятельности кишечного анастомоза
|
CN102133190A
(zh)
*
|
2011-03-16 |
2011-07-27 |
中国药科大学 |
一种转铁蛋白纳米粒及其制备方法和用途
|
CO6540157A1
(es)
|
2011-04-15 |
2012-10-16 |
Univ Antioquia |
Proceso continuo para la elaboracion de nanoparticulas y nanoparticulas obtenidas mediante dicho proceso
|
BR112013027674A2
(pt)
|
2011-04-28 |
2016-09-06 |
Abraxis Bioscience Llc |
"usos de composições de nanopartículas, composições compreendendo as referidas nanopartículas e cateter com uma agulha".
|
US10179801B2
(en)
|
2011-08-26 |
2019-01-15 |
Sanford-Burnham Medical Research Institute |
Truncated LYP-1 peptides and methods and compositions using truncated LYP-1 peptides
|
CA2853949A1
(en)
|
2011-11-01 |
2013-05-10 |
Celgene Corporation |
Methods for treating cancers using oral formulations of cytidine analogs
|
WO2013085902A1
(en)
|
2011-12-05 |
2013-06-13 |
The University Of Texas M.D. |
Combination therapy methods for treating an inflammatory breast cancer
|
WO2013084207A1
(pt)
|
2011-12-07 |
2013-06-13 |
Universidade Do Minho |
Formulações micelares proteicas e respectivo método de produção
|
PL2790675T3
(pl)
|
2011-12-14 |
2019-12-31 |
Abraxis Bioscience, Llc |
Zastosowanie polimerowych rozczynników do liofilizacji lub zamrażania cząstek
|
RU2499991C2
(ru)
*
|
2011-12-14 |
2013-11-27 |
Государственное бюджетное образовательное учреждение высшего профессионального образования "Северный государственный медицинский университет" Министерства здравоохранения и социального развития Российской Федерации |
Способ дифференциальной диагностики типа гепаторенального синдрома алкогольного генеза
|
US9827191B2
(en)
|
2012-05-03 |
2017-11-28 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
US11596599B2
(en)
|
2012-05-03 |
2023-03-07 |
The Johns Hopkins University |
Compositions and methods for ophthalmic and/or other applications
|
WO2013166408A1
(en)
|
2012-05-03 |
2013-11-07 |
Kala Pharmaceuticals, Inc. |
Pharmaceutical nanoparticles showing improved mucosal transport
|
EP4008355A1
(de)
|
2012-05-03 |
2022-06-08 |
Kala Pharmaceuticals, Inc. |
Pharmazeutische nanopartikel mit verbessertem mukosalem transport
|
MX2015001194A
(es)
|
2012-07-27 |
2015-11-23 |
Izumi Technology Llc |
Composiciones inhibidoras de eflujo y metodos de tratamiento que usan las mismas.
|
RU2674249C2
(ru)
|
2012-11-05 |
2018-12-06 |
НэнтБайо, Инк. |
Замещенные производные индол-5-ола и их терапевтическое применение
|
RU2015121347A
(ru)
|
2012-11-05 |
2016-12-27 |
НЭНТ ХОЛДИНГЗ АйПИ, ЭлЭлСи |
Производные, содержащие циклическую сульфонамидную группу, в качестве ингибиторов сигнального пути hedgenog
|
US9149455B2
(en)
|
2012-11-09 |
2015-10-06 |
Abraxis Bioscience, Llc |
Methods of treating melanoma
|
ES2821528T3
(es)
*
|
2012-11-14 |
2021-04-26 |
Grace W R & Co |
Composiciones que contienen un material biológicamente activo y un óxido inorgánico no ordenado
|
JP5999765B2
(ja)
*
|
2012-12-07 |
2016-09-28 |
バイオアバイラビリティ,インク. |
栄養学的に使用するための高濃度自己マイクロエマルジョン化コエンザイムq10調製物
|
PT106738B
(pt)
|
2013-01-09 |
2015-06-08 |
Hovione Farmaciencia Sa |
Método para o controlo do fenómeno de degradação difusional de ostwald (ostwald ripening) no processamento de partículas de um ingrediente farmacêutico
|
US9511046B2
(en)
|
2013-01-11 |
2016-12-06 |
Abraxis Bioscience, Llc |
Methods of treating pancreatic cancer
|
KR102148551B1
(ko)
|
2013-02-11 |
2020-08-26 |
아브락시스 바이오사이언스, 엘엘씨 |
흑색종을 치료하는 방법
|
ITBN20130001A1
(it)
*
|
2013-02-19 |
2014-08-20 |
Prodal S C A R L |
Particelle biopolimeriche sub-micrometriche per la veicolazione di composti attivi in campo alimentare, farmaceutico e cosmetico e procedimento per la loro preparazioneparticelle biopolimeriche sub-micrometriche per la veicolazione di composti attivi
|
CN105228612A
(zh)
|
2013-03-12 |
2016-01-06 |
阿布拉科斯生物科学有限公司 |
治疗肺癌的方法
|
NZ630367A
(en)
|
2013-03-13 |
2017-02-24 |
Abraxis Bioscience Llc |
Methods of treatment of pediatric solid tumor
|
ES2881851T3
(es)
|
2013-03-14 |
2021-11-30 |
Abraxis Bioscience Llc |
Métodos para tratar el cáncer de vejiga
|
CA2905207C
(en)
|
2013-03-15 |
2022-04-12 |
Brent Buchine |
Portable drug mixing and delivery system and method
|
US10391262B2
(en)
|
2014-03-18 |
2019-08-27 |
Windgap Medical, Inc. |
Removable actuating cap for use with an auto-injector assembly
|
US9907910B2
(en)
|
2013-03-15 |
2018-03-06 |
Windgap Medical, Inc. |
Portable drug mixing and delivery device and associated methods
|
US10569017B2
(en)
|
2013-03-15 |
2020-02-25 |
Windgap Medical, Inc. |
Portable drug mixing and delivery device and associated methods
|
CN105377261B
(zh)
|
2013-03-15 |
2017-12-15 |
南特生物科学公司 |
取代的吲哚‑5‑酚衍生物和它们的治疗应用
|
KR101329646B1
(ko)
|
2013-05-02 |
2013-11-14 |
주식회사 지니스 |
표적지향증폭형 항암나노입자 및 이의 제조방법
|
CN103393632B
(zh)
*
|
2013-07-26 |
2015-05-13 |
齐鲁制药(海南)有限公司 |
一种卡巴他赛药物组合物及其制备方法
|
CN104368007A
(zh)
*
|
2013-08-12 |
2015-02-25 |
于湛 |
可注射蛋白基花样结构载药微纳材料与内耳跨膜给药缓释制剂及其制备方法
|
KR20150047336A
(ko)
|
2013-10-24 |
2015-05-04 |
삼성전자주식회사 |
나노입자, 이를 제조하는 방법, 및 이의 용도
|
CN104758942A
(zh)
*
|
2014-01-02 |
2015-07-08 |
国家纳米科学中心 |
基于蛋白质的药理活性物质组合物及其制备方法和应用
|
CN103705469B
(zh)
*
|
2014-01-03 |
2016-01-20 |
中国医学科学院药用植物研究所 |
一种和厚朴酚纳米粒及其制备方法
|
US10456361B2
(en)
*
|
2014-02-14 |
2019-10-29 |
Boston Scientific Scimed, Inc. |
Rapidly degrading embolic particles with therapeutic agent release
|
CN103861115B
(zh)
*
|
2014-03-18 |
2017-04-19 |
常州市第一人民医院 |
一种血红蛋白纳米粒及其制备方法
|
WO2015195634A1
(en)
|
2014-06-17 |
2015-12-23 |
Celgne Corporation |
Methods for treating epstein-barr virus (ebv) associated cancers using oral formulations of 5-azacytidine
|
WO2015018380A2
(en)
|
2014-07-03 |
2015-02-12 |
Cspc Zhongqi Pharmaceutical Technology(Shijiazhuang)Co., Ltd. |
Therapeutic nanoparticles and the preparation methods thereof
|
US11116903B2
(en)
|
2014-08-18 |
2021-09-14 |
Windgap Medical, Inc |
Compression seal for use with a liquid component storage vial of an auto-injector
|
EP3183020B1
(de)
|
2014-08-18 |
2020-04-08 |
Windgap Medical, Inc. |
Tragbare arzneimittelmisch- und -ausgabevorrichtung und zugehörige verfahren
|
EP3241563B1
(de)
*
|
2014-12-05 |
2020-03-04 |
Kitayama, Yukiya |
In-vivo-stealth-nanopartikel
|
CN105727303B
(zh)
*
|
2014-12-12 |
2019-06-28 |
四川科伦药物研究院有限公司 |
一种高载卡巴他赛药物的白蛋白组合物及其制剂和制备方法
|
CN104490797A
(zh)
*
|
2014-12-22 |
2015-04-08 |
深圳海王药业有限公司 |
一种多相稳定的白蛋白结合型卡巴他塞
|
RU2701188C2
(ru)
|
2015-02-27 |
2019-09-25 |
Нэнтбайосайенс, Инк. |
Производные пиримидина в качестве ингибиторов киназы и их терапевтические применения
|
US10705070B1
(en)
|
2015-03-05 |
2020-07-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and poorly water soluble drug
|
US10527604B1
(en)
|
2015-03-05 |
2020-01-07 |
Abraxis Bioscience, Llc |
Methods of assessing suitability of use of pharmaceutical compositions of albumin and paclitaxel
|
CN106137969B
(zh)
*
|
2015-04-03 |
2020-05-15 |
四川科伦药物研究院有限公司 |
多西他赛白蛋白纳米粒药物组合物及其制备方法及应用
|
JP6983660B2
(ja)
|
2015-05-08 |
2021-12-17 |
スペクトラル プラットフォームス インコーポレイテッド |
アルブミンに基づく非共有結合性複合体およびその使用方法
|
US20160346219A1
(en)
|
2015-06-01 |
2016-12-01 |
Autotelic Llc |
Phospholipid-coated therapeutic agent nanoparticles and related methods
|
WO2016210423A2
(en)
|
2015-06-25 |
2016-12-29 |
Sanford Burnham Prebys Medical Discovery Institute |
Compositions for delivery to and treatment of atherosclerotic plaques
|
PL3313401T3
(pl)
|
2015-06-29 |
2022-02-07 |
Abraxis Bioscience, Llc |
Nanocząsteczki zawierające sirolimus i albuminę do stosowania w leczeniu nowotworów z komórek epitelioidnych
|
CN105055341A
(zh)
*
|
2015-08-13 |
2015-11-18 |
黑龙江泰华源生物技术有限责任公司 |
一种紫杉醇白蛋白结合型冻干制剂及其制备方法
|
CN108290000B
(zh)
|
2015-08-13 |
2021-03-19 |
温德加普医疗股份有限公司 |
具有无菌特征部的混合和注射装置
|
CN105816885A
(zh)
*
|
2016-04-15 |
2016-08-03 |
北京大学 |
一种药物白蛋白纳米粒的制备及其应用方法
|
EP4062941A1
(de)
*
|
2016-04-29 |
2022-09-28 |
Rousselot B.V. |
Proteinbasierter trägerstoff für pharmazeutische wirkstoffe
|
BE1023653B1
(nl)
*
|
2016-04-29 |
2017-06-07 |
Rousselot B.V. |
Eiwit gebaseerd excipient voor actieve farmaceutische stoffen
|
CN105944109B
(zh)
*
|
2016-05-03 |
2019-06-11 |
四川大学 |
一种肾小球靶向的蛋白纳米颗粒药物组合物及其用途
|
CN106310221B
(zh)
*
|
2016-08-25 |
2019-11-22 |
齐鲁制药有限公司 |
一种含有卡非佐米的药物组合物及其制备方法
|
EP3509643A1
(de)
*
|
2016-09-06 |
2019-07-17 |
Mayo Foundation for Medical Education and Research |
Paclitaxel-albumin-bindende wirkstoffzusammensetzungen und verfahren zur verwendung und herstellung davon
|
MX2019003988A
(es)
*
|
2016-10-10 |
2019-08-14 |
Abraxis Bioscience Llc |
Formulaciones de nanoparticulas y sus metodos de fabricacion y uso.
|
ES2918976T3
(es)
*
|
2016-11-30 |
2022-07-21 |
Dukebox Sp Z O O |
Un método para fabricar una solución de nanopartículas de ácido acetilsalicílico o diosmina o drotaverina
|
US11105747B2
(en)
|
2017-03-20 |
2021-08-31 |
Spectral Platforms, Inc. |
Spectroscopic methods to detect and characterize microorganisms
|
EP3615011A4
(de)
*
|
2017-04-24 |
2021-01-06 |
ZY Therapeutics Inc. |
Pharmazeutische zusammensetzung zur in-vivo-verabreichung, verfahren zur herstellung eines weitgehend wasserlöslichen pharmakologischen wirkstoffs
|
CN107412783B
(zh)
*
|
2017-04-28 |
2020-09-22 |
中国人民解放军军事医学科学院毒物药物研究所 |
一种包裹有难溶于水药物的蛋白质颗粒的制备方法
|
WO2018204392A1
(en)
|
2017-05-02 |
2018-11-08 |
Stanford Burnham Prebys Medical Discovery Institute |
Tumor associated monocyte/macrophage binding peptide and methods of use thereof
|
US10800760B2
(en)
|
2017-05-31 |
2020-10-13 |
Nantbio, Inc. |
Trk inhibition
|
US10738033B2
(en)
|
2017-05-31 |
2020-08-11 |
Nantbio, Inc. |
Trk inhibition
|
WO2019016692A1
(en)
*
|
2017-07-21 |
2019-01-24 |
Emcure Pharmaceuticals Limited |
PARTICLE SIZE STABILIZATION OF PROTEIN-RELATED PARTICLES AND RELATED METHODS
|
CN107412172A
(zh)
*
|
2017-08-04 |
2017-12-01 |
南京拉克森生物医药科技有限公司 |
一种紫杉醇白蛋白纳米混悬剂冻干粉及其制备工艺
|
US20200230068A1
(en)
*
|
2017-08-25 |
2020-07-23 |
Nal Pharmaceutical Group Limited |
Compositions and methods of delivery of pharmacological agents
|
AU2018360766A1
(en)
|
2017-11-06 |
2020-05-21 |
Rapt Therapeutics, Inc. |
Anticancer agents
|
CN112188892A
(zh)
|
2018-03-20 |
2021-01-05 |
阿布拉科斯生物科学有限公司 |
通过mTOR抑制剂和白蛋白的纳米颗粒的施用治疗中枢神经系统障碍的方法
|
CN108524452A
(zh)
*
|
2018-05-08 |
2018-09-14 |
辽宁大学 |
一种紫杉醇白蛋白纳米粒的制备方法和应用
|
SG11202011462SA
(en)
|
2018-05-22 |
2020-12-30 |
Abraxis Bioscience Llc |
Methods and compositions for treating pulmonary hypertension
|
WO2020151733A1
(en)
*
|
2019-01-22 |
2020-07-30 |
Novagenesis Therapeutix (Hk) Limited |
Albumin nanoparticles, the making method, and uses thereof
|
CA3127985A1
(en)
|
2019-02-04 |
2020-08-13 |
University Of Tartu |
Bi-specific extracellular matrix binding peptides and methods of use thereof
|
WO2020231855A1
(en)
|
2019-05-10 |
2020-11-19 |
Nant Holdings Ip, Llc |
Nogapendekin alfa-inbakicept for immune stimulant therapies and treatment of viral infections
|
MX2022004989A
(es)
|
2019-10-28 |
2022-07-21 |
Abraxis Bioscience Llc |
Composiciones farmaceuticas de albumina y rapamicina.
|
US11318189B1
(en)
|
2020-05-13 |
2022-05-03 |
Nantcell, Inc. |
IL-15 agonist drug combinations for immune therapy
|
CN114681408B
(zh)
*
|
2020-12-26 |
2023-06-23 |
四川汇宇制药股份有限公司 |
白蛋白结合型紫杉醇纳米粒的制备方法
|
EP4035655A1
(de)
*
|
2021-02-01 |
2022-08-03 |
Oxford University Innovation Limited |
Immunmodulierende teilchen
|
EP4036580A1
(de)
*
|
2021-02-01 |
2022-08-03 |
Oxford University Innovation Limited |
Mit arzneimittel beladenes kavitationsmittel
|
WO2024081674A1
(en)
|
2022-10-11 |
2024-04-18 |
Aadi Bioscience, Inc. |
Combination therapies for the treatment of cancer
|